Counterfeit drugs: a global problem
30 March 2016
In a recent issue of European Pharmaceutical Review, David Shore from Pfizer discussed his company’s progress in combatting the illegal trade of counterfeit drugs.
Promise of iPS-based research set to reach patients, Nobel winner says
30 March 2016
Japan's deep research bet on regenerative medicines from induced pluripotent stem cells (iPS) is set to move from the lab to patients soon for some of the most vexing medical ailments, a noted expert in the field told Nikkei Asian Review.
South Korean startup biotechs gain government, banking funding lift
30 March 2016
New life science firms hoping to get off the ground in South Korea will be able to receive extra funding help as the government has announced plans to boost more startups.
Antibiotics get a boost from stabilizing frog foam delivery
30 March 2016
Scottish researchers have turned to an unlikely source to deliver antibiotics: the protein-based foam produced by Trinidadian frogs to nest and protect their eggs. As part of a presentation at the Microbiology Society's Annual Conference in Liverpool, the team announced that the nontoxic substance could help prevent infections.
World’s older population grows dramatically
29 March 2016
The world’s older population continues to grow at an unprecedented rate. Today, 8.5 percent of people worldwide (617 million) are aged 65 and over. According to a new report, “An Aging World: 2015,” this percentage is projected to jump to nearly 17 percent of the world’s population by 2050 (1.6 billion).
India's pharma firms expand globally as M&A heats up
29 March 2016
Medium- to large-sized Indian pharmaceutical companies are aggressively pursuing international acquisitions to strengthen their market presence across developed and emerging markets, and to gain a foothold in markets they are currently not strong in, according to new analysis by the Associated Chambers of Commerce and Industry of India (Assocham) and Hyderabad-based Sathguru Management Consultants.
Biopharmas still seeing values slide despite market recovery
28 March 2016
We are only a few days away from the end of the first quarter and it will certainly be a period that the biopharmaceutical sector will want to quickly forget. Year to date, the new BioWorld Biopharmaceutical Index, which combines group members from the BioWorld Blue Chip Biotech Index and BioWorld Pharma Index, has tumbled 23 percent – probably the sector's worst start to a year for almost 20 years.
South Korean team developing graphene-based patch for monitoring and treating diabetes
28 March 2016
Researchers at South Korea's Institute for Basic Science are developing a drug-delivering glucose monitoring microneedle patch made of gold-doped graphene. It showed promise on diabetic mice, according to a just-published paper in Nature Nanotechnology.
China, in typical fashion, arrests dozens as drug oversight draws attention
28 March 2016
In a typical response to publicity that its pharma supply chain has been breached, China has rounded up dozens of suspects as it investigates an operation said to have illegally sold vaccines that may not have been safely stored or shipped.
Pharma's doctor payments do pay off, with more money yielding more scripts: ProPublica
25 March 2016
Doctors deny that speaking fees, free meals, entertainment and other pharma incentives actually change their prescribing habits. They're independent, objective, too high-minded to be influenced by money.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Four cancer centers opened in Russia in 2023
26 April 2024
Russia and the UAE can simplify the drug registration process
26 April 2024
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024